Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul-Aug;9(7-8):E490-3.
doi: 10.5489/cuaj.2319.

Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases

Quentin-Côme Le Clerc  1 , Emilie Lecornet  1 , Gregoire Leon  1 , Jerome Rigaud  1 , Pascal Glemain  1 , Julien Branchereau  1 , Georgess Karam  1
Affiliations

Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases

Quentin-Côme Le Clerc et al. Can Urol Assoc J. 2015 Jul-Aug.

Abstract

Introduction: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients.

Methods: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9-11).

Results: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine (p = 0. 22).

Conclusions: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft.

PubMed Disclaimer

References

    1. Schnuelle P, Lorenz D, Trede M, et al. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998;9:2135–41. - PubMed
    1. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Transplant Proc. 2002;34:722. doi: 10.1016/S0041-1345(02)02624-6. - DOI - PubMed
    1. U.S. Renal Data System Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USDRDS 2003 Annual Data Report 2003.
    1. Kleinclauss FM, Neuzillet Y, Tillou X, et al. Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipient: Multicenter study from Renal Transplantation Committee of French Urological Association. Urology. 2008;72:1366–70. doi: 10.1016/j.urology.2008.03.018. - DOI - PubMed
    1. Hoda MR, Hamza A, Greco F, et al. Management of localized prostate cancer by retropubic radical prostatectomy in patients after renal transplantation. Nephrol Dial Transplant. 2010;25:3416–20. doi: 10.1093/ndt/gfq193. - DOI - PubMed